Amiodarone Trial After Esophageal Surgery
Phase 2
90
about 2.2 years
18+
1 site in OR
What this study is about
This trial is testing if amiodarone can help prevent atrial fibrillation (AF) after minimally invasive esophagectomy for esophageal cancer. Atrial fibrillation is an irregular heart rhythm that can occur after this surgery. The goal is to see if giving amiodarone helps reduce AF in patients with esophageal cancer who have undergone MIE.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Saline
- 2.Take Amiodarone Hydrochloride
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Anti-arrhythmic Agent (Adrenergic beta-Antagonists)
oral (Oral Tablet)
Secondary: Hospital LOS, ICU length of stay (LOS), Incidence and type of adverse events
Oncology, Cardiology / Heart